Skip to content

Clinical trials

Completed Observational Epilepsies, Partial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Phase: Observational Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20072
20082
20091
20101
20116
20123
20151
20161
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)7
GlaxoSmithKline2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
UCB Pharma GmbH2
Atlantic University1
Eisai GmbH1
Fondation Ophtalmologique Adolphe de Rothschild1
Institut National de la Santé Et de la Recherche Médicale, France1
Janssen Cilag Pharmaceutica S.A.C.I., Greece1
King's College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial27
Epilepsy14
Seizures6
Lennox Gastaut Syndrome3
Epilepsy, Generalized2
Spasms, Infantile2
Abnormalities, Multiple1
Communicable Diseases1
Communication Disorders1
Drug Resistant Epilepsy1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.